Liévin-Le Moal Vanessa, Sarrazin-Davila Luis E, Servin Alain L
Faculté de Pharmacie, Institut National de la Santé et de la Recherche Médicale, Université Paris XI, UMR-S 756 Signalisation et Physiopathologie des Cellules Epithéliales, Châtenay-Malabry, France.
Pediatrics. 2007 Oct;120(4):e795-803. doi: 10.1542/peds.2006-2930. Epub 2007 Sep 3.
Previous studies have shown that selected strains of Lactobacillus have the capacity to antagonize rotavirus-induced diarrhea. However, only a few reports have documented their efficacy against nonrotavirus diarrhea. This study involved an experimental investigation and a clinical trial of the antisecretory activity of Lactobacillus acidophilus strain LB in the context of nonrotavirus diarrhea.
The activity of a culture of L. acidophilus LB or of the lyophilized, heat-killed L. acidophilus LB bacteria plus their spent culture medium was tested in inhibiting the formation of fluid-formed domes in cultured human intestinal Caco-2/TC7 cell monolayers infected with diarrheagenic, diffusely adhering Afa/Dr Escherichia coli C1845 bacteria. A randomized, double-blind, placebo-controlled clinical trial of male or female children who were 10 months of age and presented with nonrotavirus, well-established diarrhea was conducted to evaluate the therapeutic efficacy of a pharmaceutical preparation that contains 10 billion heat-killed L. acidophilus LB plus 160 mg of spent culture medium.
Infection of the cells with C1845 bacteria that were treated with L. acidophilus LB culture or the lyophilized, heat-killed L. acidophilus LB bacteria plus their culture medium produced a dosage-dependent decrease in the number of fluid-formed domes as compared with cells that were infected with untreated C1845 bacteria. The clinical results show that in selected and controlled homogeneous groups of children with well-established, nonrotavirus diarrhea, adding lyophilized, heat-killed L. acidophilus LB bacteria plus their culture medium to a solution of oral rehydration solution shortened by 1 day the recovery time (ie, the time until the first normal stool was passed) as compared with children who received placebo oral rehydration solution.
Heat-killed L. acidophilus LB plus its culture medium antagonizes the C1845-induced increase in paracellular permeability in intestinal Caco-2/TC7 cells and produces a clinically significant benefit in the management of children with nonrotavirus, well-established diarrhea.
先前的研究表明,某些乳酸杆菌菌株有能力对抗轮状病毒引起的腹泻。然而,仅有少数报告记录了它们对非轮状病毒腹泻的疗效。本研究涉及嗜酸乳杆菌LB菌株在非轮状病毒腹泻情况下抗分泌活性的实验研究和临床试验。
测试嗜酸乳杆菌LB培养物或冻干、热灭活的嗜酸乳杆菌LB细菌及其用过的培养基在抑制感染致泻性、弥漫性黏附的Afa/Dr大肠杆菌C1845细菌的培养人肠道Caco-2/TC7细胞单层中液泡形成的活性。对10个月大、患有非轮状病毒且腹泻已确诊的男童或女童进行了一项随机、双盲、安慰剂对照的临床试验,以评估一种含有100亿个热灭活嗜酸乳杆菌LB加160毫克用过的培养基的药物制剂的治疗效果。
与感染未处理的C1845细菌的细胞相比,用嗜酸乳杆菌LB培养物或冻干、热灭活的嗜酸乳杆菌LB细菌及其培养基处理过的C1845细菌感染细胞后,液泡形成数量呈剂量依赖性减少。临床结果表明,在选定的、经过对照的非轮状病毒腹泻确诊患儿同质组中,与接受安慰剂口服补液溶液的儿童相比,在口服补液溶液中添加冻干、热灭活的嗜酸乳杆菌LB细菌及其培养基可使恢复时间(即首次排出正常粪便的时间)缩短1天。
热灭活的嗜酸乳杆菌LB及其培养基可对抗C1845诱导的肠道Caco-2/TC7细胞旁细胞通透性增加,并在治疗非轮状病毒腹泻确诊患儿方面产生具有临床意义的益处。